OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| OSUR | ORASURE TECHNOLOGIES INC | 2025-12-01 18:55:37 | 2.42 | 0.01 | 0.41 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OSUR | 0001116463 | ORASURE TECHNOLOGIES INC | US68554V1089 | 529900GNNJPNM4XHXQ77 | 364370966 | Nasdaq | 3841 | Surgical & Medical Instruments & Apparatus | 1231 | DE | 220 E FIRST ST | BETHLEHEM | PA | 18015 | UNITED STATES | US | 5036416115 | 220 E FIRST ST, BETHLEHEM, PA, 18015 | 220 E FIRST ST, BETHLEHEM, PA, 18015 | — | Medical Devices | — | — | — | — | 314,835,036 | 72,265,000 | 71,733,530 | OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test. | 2025-11-27 18:54:58 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 314,835,036 | -53,458,636 | -14.5152 | 74,800,131 | 1,003,863 | 1.3603 |
| 2023 | 368,293,672 | 170,549,980 | 86.248 | 73,796,268 | 551,461 | 0.7529 |
| 2022 | 197,743,692 | -530,241,110 | -72.8368 | 73,244,807 | 940,015 | 1.3001 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Kathleen G. Weber | Chief Product Officer | 2024 | 488,000 | 0 | 661,309 | 233,508 | 14,921 | 1,397,738 |
| Carrie Eglinton Manner | Chief Executive Officer, President | 2024 | 721,000 | 0 | 4,187,301 | 689,997 | 4,000 | 5,602,298 |
| Ken Mcgrath | Chief Financial Officer | 2024 | 497,500 | 0 | 943,816 | 238,054 | 4,000 | 1,683,370 |
| Ken Mcgrath | Chief Financial Officer | 2023 | 483,000 | 0 | 672,104 | 369,495 | 4,000 | 1,528,599 |
| Carrie Eglinton Manner | Chief Executive Officer, President | 2023 | 721,000 | 0 | 4,873,637 | 1,103,130 | 4,000 | 6,701,767 |
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 501 |
| 2023 | 638 |
| 2022 | 840 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 185,827,000 | 405,472,000 | 387,479,000 |
| Cost Of Revenue | 106,437,000 | 233,820,000 | 239,842,000 |
| Gross Profit | 79,390,000 | 171,652,000 | 147,637,000 |
| Research And Development Expenses | 26,047,000 | 33,728,000 | 36,237,000 |
| General And Administrative Expenses | 46,215,000 | 58,191,000 | 68,206,000 |
| Operating Expenses | 107,640,000 | 138,968,000 | 170,594,000 |
| Operating Income | -28,250,000 | 32,684,000 | -22,957,000 |
| Net Income | -19,500,000 | 53,655,000 | -17,934,000 |
| Earnings Per Share Basic | -0.26 | 0.73 | -0.25 |
| Earnings Per Share Diluted | -0.26 | 0.72 | -0.25 |
| Weighted Average Shares Outstanding Basic | 74,434,000 | 73,348,000 | 72,505,000 |
| Weighted Average Shares Outstanding Diluted | 74,434,000 | 74,389,000 | 72,505,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 267,763,000 | 290,407,000 | 83,980,000 |
| Marketable Securities Current | — | 0 | 26,867,000 |
| Accounts Receivable | 23,816,000 | 40,171,000 | 70,797,000 |
| Inventories | 34,197,000 | 47,614,000 | 96,232,000 |
| Non Trade Receivables | — | 5,700,000 | 5,728,000 |
| Other Assets Current | 3,488,000 | 2,226,000 | 41,569,000 |
| Total Assets Current | 333,220,000 | 386,459,000 | 325,718,000 |
| Marketable Securities Non Current | — | — | 0 |
| Property Plant And Equipment | 45,105,000 | 45,420,000 | 59,413,000 |
| Other Assets Non Current | 1,526,000 | 1,218,000 | 1,087,000 |
| Total Assets Non Current | 58,692,000 | 58,266,000 | 118,990,000 |
| Total Assets | 479,659,000 | 482,845,000 | 444,708,000 |
| Accounts Payable | 8,173,000 | 13,151,000 | 39,349,000 |
| Deferred Revenue | 3,000,000 | 1,200,000 | 2,273,000 |
| Short Term Debt | — | — | — |
| Other Liabilities Current | — | — | — |
| Total Liabilities Current | 33,483,000 | 39,536,000 | 70,392,000 |
| Long Term Debt | — | — | — |
| Other Liabilities Non Current | 494,000 | 696,000 | 581,000 |
| Total Liabilities Non Current | 35,838,000 | 12,638,000 | 10,692,000 |
| Total Liabilities | 69,321,000 | 52,174,000 | 81,084,000 |
| Common Stock | 0 | 0 | 0 |
| Retained Earnings | -103,431,000 | -83,931,000 | -138,387,000 |
| Accumulated Other Comprehensive Income | -24,360,000 | -14,941,000 | -18,435,000 |
| Total Shareholders Equity | 410,338,000 | 430,671,000 | 363,624,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 10,872,000 | 20,936,000 | 15,308,000 |
| Share Based Compensation Expense | 11,920,000 | 10,729,000 | 11,622,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | -15,872,000 | -31,116,000 | 25,162,000 |
| Change In Inventories | -13,096,000 | -48,228,000 | 43,048,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | -7,577,000 | -26,976,000 | 3,963,000 |
| Change In Other Liabilities | -6,443,000 | -3,384,000 | 1,370,000 |
| Cash From Operating Activities | 27,374,000 | 141,583,000 | -47,202,000 |
| Purchases Of Marketable Securities | 53,244,000 | 74,652,000 | 22,873,000 |
| Sales Of Marketable Securities | 53,052,000 | 102,440,000 | 47,415,000 |
| Acquisition Of Property Plant And Equipment | 3,797,000 | 5,802,000 | 6,774,000 |
| Acquisition Of Business | 5,037,000 | — | — |
| Other Investing Activities | — | 0 | — |
| Cash From Investing Activities | -39,026,000 | 66,154,000 | 21,085,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 3,548,000 | 1,901,000 | 2,254,000 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -4,176,000 | -3,023,000 | -3,828,000 |
| Change In Cash | -22,644,000 | 206,427,000 | -32,782,000 |
| Cash At End Of Period | 267,763,000 | 290,407,000 | 83,980,000 |
| Income Taxes Paid | 1,800,000 | — | 9,446,000 |
| Interest Paid | — | — | — |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | -0.26 | 0.73 | -0.25 |
| Price To Earnings Ratio | -13.8846 | 11.2329 | -19.28 |
| Earnings Growth Rate | -135.6164 | -392 | -21.875 |
| Price Earnings To Growth Ratio | 0.1024 | -0.0287 | 0.8814 |
| Book Value Per Share | 5.5128 | 5.8716 | 5.0152 |
| Price To Book Ratio | 0.6548 | 1.3966 | 0.9611 |
| Ebitda | -6,828,000 | 74,591,000 | 6,820,000 |
| Enterprise Value | — | — | — |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | — | — | — |
| Capital Expenditures | 10,557,000 | 6,943,000 | -13,443,000 |
| Free Cash Flow | 16,817,000 | 134,640,000 | -33,759,000 |
| Return On Equity | -0.0475 | 0.1246 | -0.0493 |
| One Year Beta | 0.9924 | 1.0554 | 1.2071 |
| Three Year Beta | 1.1365 | 1.0109 | 0.7723 |
| Five Year Beta | 0.808 | 0.8438 | 0.8513 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Kenny John P. | Director | 2025-09-24 | 6,118 | A | 153,322 |
| McGrath Kenneth J | Chief Financial Officer | 2025-08-08 | 12,524 | D | 448,463 |
| McMahon Robert W. | Director | 2025-07-31 | 7,317 | D | 99,919 |
| Kenny John P. | Director | 2025-06-24 | 6,657 | A | 147,204 |
| EGLINTON MANNER CARRIE | Director, President & CEO | 2025-06-04 | 335,710 | A | 2,024,076 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | 2025-09-30 | 5,043,642 | 1,571,228 | 3.21 |
| CIBC Private Wealth Group LLC | 2025-09-30 | 241 | 75 | 3.2133 |
| Sunbelt Securities, Inc. | 2025-09-30 | 193 | 60 | 3.2167 |
| COLDSTREAM CAPITAL MANAGEMENT INC | 2025-09-30 | 51,418 | 16,018 | 3.21 |
| Advisory Services Network, LLC | 2025-09-30 | 642 | 200 | 3.21 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| JAMES ADVANTAGE FUNDS | 2025-09-30 | JAMES MICRO CAP FUND | JMCRX | 9,526 | 30,578.46 | 0.1104 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class C | RYCMX | 106 | 340.26 | 0.0051 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class A | RYAKX | 106 | 340.26 | 0.0051 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class H | RYMKX | 106 | 340.26 | 0.0051 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class H | RYRHX | 176 | 564.96 | 0.0046 |